Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 84

    1.

    Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial.

    Bostom AG, Carpenter MA, Hunsicker L, Jacques PF, Kusek JW, Levey AS, McKenney JL, Mercier RY, Pfeffer MA, Selhub J; FAVORIT Study Investigators.

    Am J Kidney Dis. 2009 Jan;53(1):121-8. Epub 2008 Nov 20.PMID: 19022547 [PubMed - indexed for MEDLINE]Related articles

    2.

    Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial.

    Bostom AG, Carpenter MA, Kusek JW, Hunsicker LG, Pfeffer MA, Levey AS, Jacques PF, McKenney J; FAVORIT Investigators.

    Am Heart J. 2006 Sep;152(3):448.e1-7.PMID: 16923411 [PubMed - indexed for MEDLINE]Related articles

    3.

    Total plasma homocysteine and arteriosclerotic outcomes in type 2 diabetes with nephropathy.

    Friedman AN, Hunsicker LG, Selhub J, Bostom AG; Collaborative Study Group.

    J Am Soc Nephrol. 2005 Nov;16(11):3397-402. Epub 2005 Sep 14.PMID: 16162814 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    C-reactive protein as a predictor of total arteriosclerotic outcomes in type 2 diabetic nephropathy.

    Friedman AN, Hunsicker LG, Selhub J, Bostom AG; Collaborative Study Group.

    Kidney Int. 2005 Aug;68(2):773-8.PMID: 16014055 [PubMed - indexed for MEDLINE]Related articles

    5.

    Clinical and nutritional correlates of C-reactive protein in type 2 diabetic nephropathy.

    Friedman AN, Hunsicker LG, Selhub J, Bostom AG.

    Atherosclerosis. 2004 Jan;172(1):121-5.PMID: 14709365 [PubMed - indexed for MEDLINE]Related articles

    6.

    The effect of N-acetylcysteine on plasma total homocysteine levels in hemodialysis: a randomized, controlled study.

    Friedman AN, Bostom AG, Laliberty P, Selhub J, Shemin D.

    Am J Kidney Dis. 2003 Feb;41(2):442-6.PMID: 12552508 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study.

    Jacques PF, Bostom AG, Selhub J, Rich S, Ellison RC, Eckfeldt JH, Gravel RA, Rozen R; National Heart, Lung and Blood Institute, National Institutes of Health.

    Atherosclerosis. 2003 Jan;166(1):49-55.PMID: 12482550 [PubMed - indexed for MEDLINE]Related articles

    8.

    Association between increased homocysteine levels and impaired fibrinolytic potential: potential mechanism for cardiovascular risk.

    Tofler GH, D'Agostino RB, Jacques PF, Bostom AG, Wilson PW, Lipinska I, Mittleman MA, Selhub J.

    Thromb Haemost. 2002 Nov;88(5):799-804.PMID: 12428097 [PubMed - indexed for MEDLINE]Related articles

    9.

    Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid.

    Ghandour H, Bagley PJ, Shemin D, Hsu N, Jacques PF, Dworkin L, Bostom AG, Selhub J.

    Kidney Int. 2002 Dec;62(6):2246-9.PMID: 12427152 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Proteinuria as a predictor of total plasma homocysteine levels in type 2 diabetic nephropathy.

    Friedman AN, Hunsicker LG, Selhub J, Bostom AG; Collaborative Study Group.

    Diabetes Care. 2002 Nov;25(11):2037-41.PMID: 12401753 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels.

    Bostom AG, Kronenberg F, Ritz E.

    J Am Soc Nephrol. 2002 Aug;13(8):2140-4.PMID: 12138147 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Hyperhomocysteinemia in renal transplant recipients.

    Friedman AN, Rosenberg IH, Selhub J, Levey AS, Bostom AG.

    Am J Transplant. 2002 Apr;2(4):308-13. Review.PMID: 12118851 [PubMed - indexed for MEDLINE]Related articles

    13.

    B vitamins and restenosis after coronary angioplasty.

    Bostom AG, Sharaf B.

    N Engl J Med. 2002 Apr 4;346(14):1093-5. No abstract available. PMID: 11936123 [PubMed - indexed for MEDLINE]Related articles

    14.

    Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour.

    Bostom AG, Jacques PF, Liaugaudas G, Rogers G, Rosenberg IH, Selhub J.

    Arterioscler Thromb Vasc Biol. 2002 Mar 1;22(3):488-91.PMID: 11884295 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Cost-effectiveness of homocysteine-lowering therapy to prevent coronary heart disease.

    Bostom AG.

    JAMA. 2002 Jan 9;287(2):190; author reply 191-2. No abstract available. PMID: 11779257 [PubMed - indexed for MEDLINE]Related articles

    16.

    Plasma total homocysteine levels among patients undergoing nocturnal versus standard hemodialysis.

    Friedman AN, Bostom AG, Levey AS, Rosenberg IH, Selhub J, Pierratos A.

    J Am Soc Nephrol. 2002 Jan;13(1):265-8.PMID: 11752047 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Effects of fenofibrate and gemfibrozil on plasma homocysteine.

    Bostom AG.

    Lancet. 2001 Nov 24;358(9295):1811-2. No abstract available. PMID: 11734262 [PubMed - indexed for MEDLINE]Related articles

    18.

    Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate.

    Bostom AG, Kronenberg F, Jacques PF, Kuen E, Ritz E, König P, Kraatz G, Lhotta K, Mann JF, Müller GA, Neyer U, Riegel W, Schwenger V, Riegler P, Selhub J.

    Atherosclerosis. 2001 Nov;159(1):219-23.PMID: 11689224 [PubMed - indexed for MEDLINE]Related articles

    19.

    Treatment of hyperhomocysteinemia in end-stage renal disease.

    Shemin D, Bostom AG, Selhub J.

    Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S91-4. Review.PMID: 11576930 [PubMed - indexed for MEDLINE]Related articles

    20.

    The kidney and homocysteine metabolism.

    Friedman AN, Bostom AG, Selhub J, Levey AS, Rosenberg IH.

    J Am Soc Nephrol. 2001 Oct;12(10):2181-9. Review.PMID: 11562419 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Serum cystatin C is an independent predictor of total homocysteine levels in stable Korean renal transplant recipients with normal serum creatinine.

    Han H, Dwyer JT, Selhub J, Jacques PF, Houser RF, Park JH, Kim YS, Bang BK, Kim S, Jung KA, Chang YK, Bostom AG.

    J Ren Nutr. 2001 Jul;11(3):149-54.PMID: 11466665 [PubMed - indexed for MEDLINE]Related articles

    22.

    Power Shortage: clinical trials testing the "homocysteine hypothesis" against a background of folic acid-fortified cereal grain flour.

    Bostom AG, Selhub J, Jacques PF, Rosenberg IH.

    Ann Intern Med. 2001 Jul 17;135(2):133-7.PMID: 11453713 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Residual renal function and mortality risk in hemodialysis patients.

    Shemin D, Bostom AG, Laliberty P, Dworkin LD.

    Am J Kidney Dis. 2001 Jul;38(1):85-90.PMID: 11431186 [PubMed - indexed for MEDLINE]Related articles

    24.

    Relationship between plasma homocysteine and vitamin status in the Framingham study population. Impact of folic acid fortification.

    Selhub J, Jacques PF, Bostom AG, Wilson PW, Rosenberg IH.

    Public Health Rev. 2000;28(1-4):117-45.PMID: 11411265 [PubMed - indexed for MEDLINE]Related articles

    25.

    The 1298A-->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine.

    Weisberg IS, Jacques PF, Selhub J, Bostom AG, Chen Z, Curtis Ellison R, Eckfeldt JH, Rozen R.

    Atherosclerosis. 2001 Jun;156(2):409-15.PMID: 11395038 [PubMed - indexed for MEDLINE]Related articles

    26.

    Chronic renal transplantation: a model for the hyperhomocysteinemia of renal insufficiency.

    Bostom AG, Kronenberg F, Gohh RY, Schwenger V, Kuen E, König P, Kraatz G, Lhotta K, Mann JF, Müller GA, Neyer U, Riegel W, Riegler P, Ritz E, Selhub J.

    Atherosclerosis. 2001 May;156(1):227-30.PMID: 11369018 [PubMed - indexed for MEDLINE]Related articles

    27.

    Renal insufficiency, vitamin B(12) status, and population attributable risk for mild hyperhomocysteinemia among coronary artery disease patients in the era of folic acid-fortified cereal grain flour.

    Liaugaudas G, Jacques PF, Selhub J, Rosenberg IH, Bostom AG.

    Arterioscler Thromb Vasc Biol. 2001 May;21(5):849-51.PMID: 11348885 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort.

    Jacques PF, Bostom AG, Wilson PW, Rich S, Rosenberg IH, Selhub J.

    Am J Clin Nutr. 2001 Mar;73(3):613-21.PMID: 11237940 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey.

    Morris MS, Bostom AG, Jacques PF, Selhub J, Rosenberg IH.

    Atherosclerosis. 2001 Mar;155(1):195-200.PMID: 11223442 [PubMed - indexed for MEDLINE]Related articles

    30.

    Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients.

    Bostom AG, Shemin D, Gohh RY, Beaulieu AJ, Bagley P, Massy ZA, Jacques PF, Dworkin L, Selhub J.

    Kidney Int Suppl. 2001 Feb;78:S246-52.PMID: 11169020 [PubMed - indexed for MEDLINE]Related articles

    31.

    Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.

    Yango A, Shemin D, Hsu N, Jacques PF, Dworkin L, Selhub J, Bostom AG.

    Kidney Int. 2001 Jan;59(1):324-7.PMID: 11135086 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Determinants of plasma total homocysteine levels in Korean chronic renal transplant recipients.

    Han H, Dwyer JT, Selhub J, Jacques PF, Park JH, Kim YS, Bang BK, Bostom AG.

    J Ren Nutr. 2000 Oct;10(4):202-7.PMID: 11070148 [PubMed - indexed for MEDLINE]Related articles

    33.

    Residual renal function in a large cohort of peritoneal dialysis patients: change over time, impact on mortality and nutrition.

    Shemin D, Bostom AG, Lambert C, Hill C, Kitsen J, Kliger AS.

    Perit Dial Int. 2000 Jul-Aug;20(4):439-44.PMID: 11007376 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Cystatin C measurement: improved detection of mild decrements in glomerular filtration rate versus creatinine-based estimates?

    Bostom AG, Dworkin LD.

    Am J Kidney Dis. 2000 Jul;36(1):205-7. No abstract available. PMID: 10873893 [PubMed - indexed for MEDLINE]Related articles

    35.

    Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.

    Bostom AG, Shemin D, Bagley P, Massy ZA, Zanabli A, Christopher K, Spiegel P, Jacques PF, Dworkin L, Selhub J.

    Circulation. 2000 Jun 20;101(24):2829-32. Erratum in: Circulation 2000 Aug 1;102(5):598. PMID: 10859289 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Treatment of mild hyperhomocysteinemia in renal transplant recipients versus hemodialysis patients.

    Bostom AG, Shemin D, Gohh RY, Beaulieu AJ, Jacques PF, Dworkin L, Selhub J.

    Transplantation. 2000 May 27;69(10):2128-31.PMID: 10852611 [PubMed - indexed for MEDLINE]Related articles

    37.

    Endpoints for homocysteine-lowering trials.

    Bostom AG, Garber C.

    Lancet. 2000 Feb 12;355(9203):511-2. No abstract available. PMID: 10682995 [PubMed - indexed for MEDLINE]Related articles

    38.

    Homocysteine: "expensive creatinine" or important modifiable risk factor for arteriosclerotic outcomes in renal transplant recipients?

    Bostom AG.

    J Am Soc Nephrol. 2000 Jan;11(1):149-51. Review. No abstract available. PMID: 10616851 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients.

    Beaulieu AJ, Gohh RY, Han H, Hakas D, Jacques PF, Selhub J, Bostom AG.

    Arterioscler Thromb Vasc Biol. 1999 Dec;19(12):2918-21.PMID: 10591669 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine.

    Bostom AG, Bausserman L, Jacques PF, Liaugaudas G, Selhub J, Rosenberg IH.

    Arterioscler Thromb Vasc Biol. 1999 Sep;19(9):2241-4.PMID: 10479668 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study.

    Bostom AG, Rosenberg IH, Silbershatz H, Jacques PF, Selhub J, D'Agostino RB, Wilson PW, Wolf PA.

    Ann Intern Med. 1999 Sep 7;131(5):352-5.PMID: 10475888 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Short-term reproducibility of total homocysteine determinations in stable renal transplant recipients.

    Beaulieu AJ, Lapane KL, Gohh RY, Selhub J, Monaco AP, Dworkin L, Rosenberg IH, Bostom AG.

    Transplant Proc. 1999 Aug;31(5):2121-3. No abstract available. PMID: 10455988 [PubMed - indexed for MEDLINE]Related articles

    43.

    Determinants of fasting plasma total homocysteine levels among chronic stable renal transplant recipients.

    Bostom AG, Gohh RY, Beaulieu AJ, Han H, Jacques PF, Selhub J, Dworkin L, Rosenberg IH.

    Transplantation. 1999 Jul 27;68(2):257-61.PMID: 10440398 [PubMed - indexed for MEDLINE]Related articles

    44.

    Prevalence of mild fasting hyperhomocysteinemia in renal transplant versus coronary artery disease patients after fortification of cereal grain flour with folic acid.

    Bostom AG, Gohh RY, Liaugaudas G, Beaulieu AJ, Han H, Jacques PF, Dworkin L, Rosenberg IH, Selhub J.

    Atherosclerosis. 1999 Jul;145(1):221-4.PMID: 10428313 [PubMed - indexed for MEDLINE]Related articles

    45.

    Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women.

    Bostom AG, Silbershatz H, Rosenberg IH, Selhub J, D'Agostino RB, Wolf PA, Jacques PF, Wilson PW.

    Arch Intern Med. 1999 May 24;159(10):1077-80.PMID: 10335684 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    The effect of folic acid fortification on plasma folate and total homocysteine concentrations.

    Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH.

    N Engl J Med. 1999 May 13;340(19):1449-54.PMID: 10320382 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Homocysteine and arteriosclerosis: subclinical and clinical disease associations.

    Bostom AG, Selhub J.

    Circulation. 1999 May 11;99(18):2361-3. No abstract available. PMID: 10318653 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Plasma total homocysteine and hemodialysis access thrombosis: a prospective study.

    Shemin D, Lapane KL, Bausserman L, Kanaan E, Kahn S, Dworkin L, Bostom AG.

    J Am Soc Nephrol. 1999 May;10(5):1095-9.PMID: 10232697 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Hyperhomocysteinemia in chronic renal disease.

    Bostom AG, Culleton BF.

    J Am Soc Nephrol. 1999 Apr;10(4):891-900. Review. No abstract available. PMID: 10203375 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Serum cystatin C as a determinant of fasting total homocysteine levels in renal transplant recipients with a normal serum creatinine.

    Bostom AG, Gohh RY, Bausserman L, Hakas D, Jacques PF, Selhub J, Dworkin L, Rosenberg IH.

    J Am Soc Nephrol. 1999 Jan;10(1):164-6.PMID: 9890323 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...